Effect of endotoxin and cytokines on lipoprotein lipase activity in mice.

Endotoxin (lipopolysaccharide [LPS]) stimulates the production of cytokines, which mediate many of the metabolic effects associated with infection. In LPS-sensitive C57B1/6 mice, LPS doses as low as 0.01 micrograms per mouse decreased adipose tissue lipoprotein lipase (LPL) activity by greater than 50%. In LPS-resistant C3H/HeJ mice, which do not produce cytokines in response to LPS, doses of LPS as high as 10 micrograms per mouse did not affect LPL activity in adipose tissue. In muscle of C57Bl/6 mice, LPL activity was decreased by 27% after 10 micrograms of LPS, whereas in C3H/HeJ mice there was no effect. These results indicate that the LPS-induced decrease in both adipose and muscle LPL activity is mediated by cytokines. Tumor necrosis factor (TNF), interleukin (IL)-1, leukemia-inhibiting factor (LIF), interferon alfa, and interferon gamma all decreased adipose tissue LPL activity in intact mice. In skeletal and cardiac muscle, only IL-1 and interferon gamma decreased LPL activity, whereas TNF, LIF, and interferon alfa had no effect. Inhibition of TNF activity blocked the increase in serum triglycerides that is characteristically observed after LPS but did not affect the ability of LPS to decrease adipose tissue LPL activity. Inhibition of IL-1 activity with IL-1 receptor antagonist partially inhibited the increase in serum triglycerides; however, the ability of LPS to decrease LPL activity in either adipose or muscle tissue was not affected. These data indicate that although TNF and IL-1 play a role in mediating the increase in serum triglyceride levels, these cytokines do not play a crucial role in the inhibition of either adipose or muscle LPL activity.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  K. Feingold,et al.  Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. , 1993, Endocrinology.

[2]  L. Chan,et al.  Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. , 1993, Journal of lipid research.

[3]  K. Feingold,et al.  Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.

[4]  W. Ettinger,et al.  Effect of interleukin-1 alpha on lipoprotein lipids in cynomolgus monkeys: comparison to tumor necrosis factor. , 1992, Biochimica et biophysica acta.

[5]  R. Nordan,et al.  Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. , 1992, Cancer research.

[6]  K. Feingold,et al.  Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo. , 1992, The Journal of clinical investigation.

[7]  Y. Yang,et al.  Characterization of interleukin-11 receptor and protein tyrosine phosphorylation induced by interleukin-11 in mouse 3T3-L1 cells. , 1992, The Journal of biological chemistry.

[8]  S. Wong,et al.  Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. , 1992, Biochimica et biophysica acta.

[9]  K. Feingold,et al.  Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  D. Remick,et al.  Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. , 1990, The American journal of pathology.

[11]  D. Gearing,et al.  Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. , 1990, Blood.

[12]  M. Serio,et al.  Multiple cytokines stimulate hepatic lipid synthesis in vivo. , 1989, Endocrinology.

[13]  K. Yamaguchi,et al.  Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. , 1989, Biochemical and biophysical research communications.

[14]  M. Serio,et al.  Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. , 1989, Endocrinology.

[15]  F. López‐Soriano,et al.  Interleukin-1 and lipid metabolism in the rat. , 1989, The Biochemical journal.

[16]  K. Feingold,et al.  Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. , 1989, Journal of lipid research.

[17]  E. Shiloni,et al.  Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. , 1989, Biochimica et biophysica acta.

[18]  W. M. Weaver,et al.  Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. , 1988, Journal of immunology.

[19]  G. Bagby,et al.  Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. , 1987, The American journal of physiology.

[20]  K. Feingold,et al.  Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.

[21]  J. Tavernier,et al.  Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.

[22]  P. Pekala,et al.  Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1. , 1986, Biochimica et biophysica acta.

[23]  P. Pekala,et al.  Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes. , 1986, Archives of biochemistry and biophysics.

[24]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. A. Bradley,et al.  Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients , 1986, The Journal of experimental medicine.

[26]  A. C. Webb,et al.  Multiple biological activities of human recombinant interleukin 1. , 1986, The Journal of clinical investigation.

[27]  B. Beutler,et al.  Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. , 1985, Journal of immunology.

[28]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[29]  C. Lang,et al.  Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats. , 1984, The Journal of surgical research.

[30]  S. Pestka,et al.  Specific molecular activities of recombinant and hybrid leukocyte interferons. , 1982, The Journal of biological chemistry.

[31]  K. Cantell,et al.  Effect of Interferon on Plasma Lipoproteins and on the Activity of Postheparin Plasma Lipases , 1982, Arteriosclerosis.

[32]  G. Bagby,et al.  Decreased Myocardial Extracellular and Muscle Lipoprotein Lipase Activities in Endotoxin-Treated Rats , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[33]  A. Cerami,et al.  Studies of endotoxin-induced decrease in lipoprotein lipase activity , 1981, The Journal of experimental medicine.

[34]  G. Bagby,et al.  Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock. , 1980, The American journal of physiology.

[35]  L. Wahl,et al.  Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. , 1978, Journal of immunology.

[36]  R. Havel,et al.  Significance of lipoprotein lipase in rat skeletal muscle. , 1977, Advances in experimental medicine and biology.

[37]  R. Havel,et al.  The significance of lipoprotein lipase in rat skeletal muscles. , 1977, Journal of lipid research.

[38]  R. Scow,et al.  Lipoprotein lipase and uptake of chylomicron triglyceride by skeletal muscle of rats. , 1976, The American journal of physiology.

[39]  W. Beisel,et al.  Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. , 1976, The Journal of infectious diseases.

[40]  W. Beisel,et al.  Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. , 1972, The Journal of infectious diseases.

[41]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.

[42]  J. H. Bragdon,et al.  Tissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat. , 1958, The Journal of clinical investigation.